Saturday January 18, 2020
Home India Spicy lies: Y...

Spicy lies: Yippee ad claims being safe, FDA disagrees

0
//

img1440393117822By NewsGram Staff Writer

After the recent Maggi ban and its subsequent upliftment, now Yippee noodles is on the path of courting controversy.

Today’s  Hindustan Times flashed a huge brightly colored advertisement that claims that Yipee is safe and bases the claim on a number of tests it underwent to prove its credibility. However, Indian Express, dated 24th August 2015, in a report claims that excessive lead has been found in the samples of Yippee noodles.

The report says that Uttar Pradesh Food and Drug Authority (FDA) recently found excess lead in ITC’s Yippee noodles. The samples tested contained lead amount  “in excess to the permissible limit”. The tested samples had 1.057 ppm of lead as against the permissible amount of below 1 ppm.

The report has been sent to the FDA Chief Commissioner for permission before filing an official case.

 

 

 

 

Next Story

FDA Wants Women Getting Breast Implants to Receive Stronger Warnings about Possible Risks and Complications

The recommendations are the agency's latest attempt to manage safety issues with the implants

0
FDA, Women, Breast Implants
FILE - A photo shows the U.S. Food & Drug Administration (FDA) campus in Silver Spring, Maryland. VOA

U.S. health officials want women getting breast implants to receive stronger warnings about the possible risks and complications. FDA.

The Food and Drug Administration said Wednesday that manufacturers should add a boxed warning – the most serious type – to information used to market and prepare patients for implants.

The recommendations are the agency’s latest attempt to manage safety issues with the implants.

FDA, Women, Breast Implants
The Food and Drug Administration said Wednesday that manufacturers should add a boxed warning – the most serious type – to information used to market and prepare patients. Pixabay

In recent years, the FDA and regulators elsewhere have grappled with a link between a rare cancer and a type of textured implant, some of which have been recalled. Separately, the agency has received thousands of reports of health problems that some women attribute to the implants, including arthritis, fatigue and muscle pain.

Also Read- First Lady Speaks on Opioids in Only Solo Trip to Capitol Hill

The FDA will take public comment on the recommendations before adopting them. (VOA)